FDA Inspection 1274174 — Pharmazell (India) Private Limited

Pharmazell (India) Private Limited — FEI 3003602532

The FDA completed an inspection of Pharmazell (India) Private Limited on May 9, 2025 in Chennai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 9, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chennai (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.